LifeTech Scientific Corporation 1302
HKEX · Hong Kong SAR China · Health Technology
HKD 1.31-0.09 (-6.45%)
Market open· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2026 (the "Reporting Period").
As the Asian markets navigate a complex landscape marked by central banks holding rates steady amid geopolitical uncertainties, investors are keenly observing the opportunities that arise from these conditions. Penny stocks, often representing smaller or newer companies, continue to capture attention for their potential to offer growth at accessible price points. Despite being a somewhat outdated term, penny stocks remain relevant as they can provide significant upside when backed by strong...
As global markets navigate the complexities of Middle East tensions and energy market volatility, investors are closely monitoring shifts in financial landscapes. Amid these conditions, penny stocks—though an outdated term—remain a focal point for those interested in smaller or newer companies with potential value. By examining stocks with solid financial foundations, investors can uncover opportunities that may offer both stability and growth potential within the Asian market.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.